Vijaya Diagnostic Centre posts Q2 FY25 PAT at Rs. 41.95 Cr
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Revenue share from the North America increased to 79% in Q2 FY25 as compared to 67% in Q2 FY24
The newly setup entity, Emcutix Biopharmaceuticals Limited, plans to significantly expand Emcure’s offerings
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency
The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power
Company receives acceptability, in principle, for ZyVac TCV making it eligible for purchase by United Nations procurement agencies
This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Subscribe To Our Newsletter & Stay Updated